"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A.

The Supervisory Councillor for Health Idemili North Local Government Area (INLGA), Dr. Nkem Okeke, Director INLGA Health ...

Deaths from cervical cancer are plummeting among young women in the US, and scientists think we have a single vaccine to ...

A study from MUSC Hollings Cancer Center shows a 62% drop in cervical cancer deaths among women under 25, attributed to HPV ...

Data from consultancy Frost & Sullivan showed that in 2020, the number of males in China eligible for HPV vaccination (aged 9 ...

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...

This study found a steep decline in cervical cancer mortality among US women younger than 25 years between 2016 and 2021.

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...

Vaccination of 27- to 45-year-olds ("mid-adults") against human papillomavirus (HPV) is less cost-effective than vaccination ...

Human Papilloma Virus Consultant for the Clinton Health Access Initiatives (CHAI), Mr. Akpan Etop, revealed that 380,671 ...

Vaccination against HPV can reduce rates of cervical cancer by up to 90 per cent. In countries where HPV vaccination rates ...